Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on: April 16,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on:April 16,2024

Transcranial direct current stimulation found to be safe, effective for tardive dyskinesia

by Lori SolomonTranscranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized

Updated on: November 27,2024

Transcranial direct current stimulation found to be safe, effective for tardive dyskinesia

by Lori SolomonTranscranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized

Updated on:November 27,2024

New brain discovery could help in the fight against obesity

byUniversity of AberdeenCredit:Current Biology(2024). DOI: 10.1016/j.cub.2024.02.074One of the largest threats to human health is obesity, but now researchers from the University of

Updated on: March 28,2024

New brain discovery could help in the fight against obesity

byUniversity of AberdeenCredit:Current Biology(2024). DOI: 10.1016/j.cub.2024.02.074One of the largest threats to human health is obesity, but now researchers from the University of

Updated on:March 28,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on: March 30,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on:March 30,2024

Rehabilitation approach combines spinal and hip stimulation to improve walking speed in patients with stroke

Updated on: September 02,2025

Rehabilitation approach combines spinal and hip stimulation to improve walking speed in patients with stroke

Updated on:September 02,2025

FDA head calls for inquiry into Alzheimer's drug review

by Matthew PerroneThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administrati

Updated on: March 30,2024

FDA head calls for inquiry into Alzheimer's drug review

by Matthew PerroneThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administrati

Updated on:March 30,2024

Neck scan could predict risk of developing cognitive decline

by Rowan Walker,University College LondonRed blood cells. Credit: PixabayA five-minute scan of blood vessels in the neck during mid-life could predict cognitive decline ten years before symptoms

Updated on: July 04,2024

Neck scan could predict risk of developing cognitive decline

by Rowan Walker,University College LondonRed blood cells. Credit: PixabayA five-minute scan of blood vessels in the neck during mid-life could predict cognitive decline ten years before symptoms

Updated on:July 04,2024

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on: February 28,2024

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on:February 28,2024

A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

by University of HelsinkiCredit: Pixabay/CC0 Public DomainA study conducted at the University of Helsinki and the Helsinki University Hospital (HUS) suggests that the APOE4 allele may also increa

Updated on: April 08,2024

A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

by University of HelsinkiCredit: Pixabay/CC0 Public DomainA study conducted at the University of Helsinki and the Helsinki University Hospital (HUS) suggests that the APOE4 allele may also increa

Updated on:April 08,2024

Professional classical musicians are not protected from dementia

by University of HelsinkiListening and practicing music have been reported to have many beneficial effects on human health. The effect of music on human brain has been previously studied in young

Updated on: March 07,2024

Professional classical musicians are not protected from dementia

by University of HelsinkiListening and practicing music have been reported to have many beneficial effects on human health. The effect of music on human brain has been previously studied in young

Updated on:March 07,2024

Estrogen drug may not benefit women with Alzheimer's dementia

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.An estrogen-like drug, raloxifene, has no demonstrated benefit on me

Updated on: February 26,2024

Estrogen drug may not benefit women with Alzheimer's dementia

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.An estrogen-like drug, raloxifene, has no demonstrated benefit on me

Updated on:February 26,2024

Research holds promise for Alzheimer's diagnostic blood test

by University of OtagoUniversity of Otago researchers have discovered a promising new marker that could help diagnose Alzheimer's disease—and all that might be required is a simple blood test

Updated on: February 28,2024

Research holds promise for Alzheimer's diagnostic blood test

by University of OtagoUniversity of Otago researchers have discovered a promising new marker that could help diagnose Alzheimer's disease—and all that might be required is a simple blood test

Updated on:February 28,2024